Published in Biochim Biophys Acta on July 14, 2010
SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation. Nature (2012) 2.96
Function and regulation of SUMO proteases. Nat Rev Mol Cell Biol (2012) 2.55
An in vivo screen to identify candidate neurogenic genes in the developing Xenopus visual system. Dev Biol (2015) 0.79
SIRT7, H3K18ac, and ELK4 Immunohistochemical Expression in Hepatocellular Carcinoma. J Pathol Transl Med (2016) 0.78
Ubc9 Is Required for Positive Selection and Late-Stage Maturation of Thymocytes. J Immunol (2017) 0.75
RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation. Nat Cell Biol (2008) 5.90
PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases. Mol Cell Biol (2002) 3.25
PDSM, a motif for phosphorylation-dependent SUMO modification. Proc Natl Acad Sci U S A (2005) 3.01
Circadian clock control by SUMOylation of BMAL1. Science (2005) 2.30
Phosphorylation of serine 303 is a prerequisite for the stress-inducible SUMO modification of heat shock factor 1. Mol Cell Biol (2003) 2.17
PIAS proteins: pleiotropic interactors associated with SUMO. Cell Mol Life Sci (2009) 1.94
Involvement of proteasome in the dynamic assembly of the androgen receptor transcription complex. J Biol Chem (2002) 1.90
Acetylation of androgen receptor enhances coactivator binding and promotes prostate cancer cell growth. Mol Cell Biol (2003) 1.89
Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor. Mol Endocrinol (2004) 1.86
The nuclear receptor interaction domain of GRIP1 is modulated by covalent attachment of SUMO-1. J Biol Chem (2002) 1.57
A two-base deletion -439delGC in the melanocortin-4 receptor promoter associated with early-onset obesity. Horm Res (2006) 1.52
Androgen receptor acetylation governs trans activation and MEKK1-induced apoptosis without affecting in vitro sumoylation and trans-repression function. Mol Cell Biol (2002) 1.48
Sumo-1 function is dispensable in normal mouse development. Mol Cell Biol (2008) 1.37
Small ubiquitin-related modifier-1 (SUMO-1) modification of the glucocorticoid receptor. Biochem J (2002) 1.33
Nrf2 regulates antioxidant gene expression evoked by oxidized phospholipids in endothelial cells and murine arteries in vivo. Circ Res (2008) 1.32
SUMO-specific protease 1 (SENP1) reverses the hormone-augmented SUMOylation of androgen receptor and modulates gene responses in prostate cancer cells. Mol Endocrinol (2008) 1.32
Glucocorticoid receptor activates poised FKBP51 locus through long-distance interactions. Mol Endocrinol (2010) 1.31
PIAS proteins promote SUMO-1 conjugation to STAT1. Blood (2003) 1.29
hZimp10 is an androgen receptor co-activator and forms a complex with SUMO-1 at replication foci. EMBO J (2003) 1.28
Long-range activation of FKBP51 transcription by the androgen receptor via distal intronic enhancers. Nucleic Acids Res (2009) 1.26
Formation of E-cadherin-mediated cell-cell adhesion activates AKT and mitogen activated protein kinase via phosphatidylinositol 3 kinase and ligand-independent activation of epidermal growth factor receptor in ovarian cancer cells. Mol Endocrinol (2005) 1.25
Inhibition of androgen receptor (AR) function by the reproductive orphan nuclear receptor DAX-1. Mol Endocrinol (2002) 1.23
SUMO-1 promotes association of SNURF (RNF4) with PML nuclear bodies. Exp Cell Res (2004) 1.21
SUMO-1 conjugation selectively modulates STAT1-mediated gene responses. Blood (2005) 1.18
Expression of androgen receptor coregulators in prostate cancer. Clin Cancer Res (2004) 1.17
SUMOylation attenuates the function of PGC-1alpha. J Biol Chem (2009) 1.14
Steroid up-regulation of FKBP51 and its role in hormone signaling. Curr Opin Pharmacol (2011) 1.12
Pattern of somatic androgen receptor gene mutations in patients with hormone-refractory prostate cancer. Lab Invest (2002) 1.06
TRIM37 defective in mulibrey nanism is a novel RING finger ubiquitin E3 ligase. Exp Cell Res (2005) 1.05
Androgen receptor-interacting protein 3 and other PIAS proteins cooperate with glucocorticoid receptor-interacting protein 1 in steroid receptor-dependent signaling. J Biol Chem (2002) 1.04
Dynamic SUMOylation is linked to the activity cycles of androgen receptor in the cell nucleus. Mol Cell Biol (2012) 1.04
SUMOylation modulates the transcription repressor function of RIP140. J Biol Chem (2008) 1.02
Effects of triaryl phosphates on mouse and human nuclear receptors. Biochem Pharmacol (2004) 1.00
ZNF451 is a novel PML body- and SUMO-associated transcriptional coregulator. J Mol Biol (2008) 0.96
SUMOylation regulates the chromatin occupancy and anti-proliferative gene programs of glucocorticoid receptor. Nucleic Acids Res (2013) 0.96
Proto-oncogene PIM-1 is a novel estrogen receptor target associating with high grade breast tumors. Mol Cell Endocrinol (2012) 0.96
Androgen receptor amplification is reflected in the transcriptional responses of Vertebral-Cancer of the Prostate cells. Mol Cell Endocrinol (2010) 0.95
Small carboxyl-terminal domain phosphatase 2 attenuates androgen-dependent transcription. EMBO J (2006) 0.94
Novel ATPase of SNF2-like protein family interacts with androgen receptor and modulates androgen-dependent transcription. Mol Biol Cell (2002) 0.91
Inhibition of small ubiquitin-related modifier-1 expression by luteinizing hormone receptor stimulation is linked to induction of progesterone receptor during ovulation in mouse granulosa cells. Endocrinology (2003) 0.91
Functional interaction of AIRE with PIAS1 in transcriptional regulation. Mol Immunol (2008) 0.89
Androgen receptor mutations in high-grade prostate cancer before hormonal therapy. Lab Invest (2003) 0.89
Down-regulation of estrogen receptor beta and transcriptional coregulator SNURF/RNF4 in testicular germ cell cancer. Eur Urol (2003) 0.89
Histone H2B ubiquitin ligases RNF20 and RNF40 in androgen signaling and prostate cancer cell growth. Mol Cell Endocrinol (2011) 0.88
Interleukins 1α and 1β as regulators of steroidogenesis in human NCI-H295R adrenocortical cells. Steroids (2011) 0.87
Attenuation of androgen receptor-dependent transcription by the serine/threonine kinase Pim-1. Lab Invest (2003) 0.87
Cooperative coactivation of estrogen receptor alpha in ZR-75 human breast cancer cells by SNURF and TATA-binding protein. J Biol Chem (2001) 0.87
Small nuclear RING finger protein stimulates the rat luteinizing hormone-beta promoter by interacting with Sp1 and steroidogenic factor-1 and protects from androgen suppression. Mol Endocrinol (2004) 0.87
Protein inhibitor of activated STAT3 (PIAS3) protein promotes SUMOylation and nuclear sequestration of the intracellular domain of ErbB4 protein. J Biol Chem (2012) 0.87
Identification of pregnane X receptor binding sites in the regulatory regions of genes involved in bile acid homeostasis. J Mol Biol (2005) 0.87
Prostaglandin 15d-PGJ(2) inhibits androgen receptor signaling in prostate cancer cells. Mol Endocrinol (2012) 0.86
Expression of the E3 SUMO-1 ligases PIASx and PIAS1 during spermatogenesis in the rat. Gene Expr Patterns (2003) 0.86
Histone demethylase GASC1--a potential prognostic and predictive marker in invasive breast cancer. BMC Cancer (2012) 0.84
PQBP-1 transgenic mice show a late-onset motor neuron disease-like phenotype. Hum Mol Genet (2003) 0.84
Nuclear mobility and activity of FOXA1 with androgen receptor are regulated by SUMOylation. Mol Endocrinol (2014) 0.83
Androgen receptor regulates nuclear trafficking and nuclear domain residency of corepressor HDAC7 in a ligand-dependent fashion. Exp Cell Res (2006) 0.83
Biochemical characterization of androgen receptor-interacting protein 4. Biochem J (2006) 0.82
TWIST overexpression predicts biochemical recurrence-free survival in prostate cancer patients treated with radical prostatectomy. Scand J Urol (2014) 0.82
Oestrogen receptors and small nuclear ring finger protein 4 (RNF4) in malignant ovarian germ cell tumours. Mol Cell Endocrinol (2009) 0.82
Transactivation assay for determination of glucocorticoid bioactivity in human serum. J Clin Endocrinol Metab (2002) 0.81
FLI-1 functionally interacts with PIASxalpha, a member of the PIAS E3 SUMO ligase family. J Biol Chem (2005) 0.81
Expression of the nuclear RING finger protein SNURF/RNF4 during rat testis development suggests a role in spermatid maturation. Mech Dev (2002) 0.81
Analysis of androgen receptor SUMOylation. Methods Mol Biol (2011) 0.81
Leukemia inhibitory factor as a regulator of steroidogenesis in human NCI-H295R adrenocortical cells. J Endocrinol (2008) 0.80
Hypoxia-inducible factor 1-induced G protein-coupled receptor 35 expression is an early marker of progressive cardiac remodelling. Cardiovasc Res (2013) 0.80
Analysis of androgen receptor activity by reporter gene assays. Methods Mol Biol (2011) 0.78
Expression and localization of androgen receptor-interacting protein-4 in the testis. Am J Physiol Endocrinol Metab (2006) 0.78
Repression and coactivation of CCAAT/enhancer-binding protein epsilon by sumoylation and protein inhibitor of activated STATx proteins. J Biol Chem (2005) 0.78
An adenosine triphosphatase of the sucrose nonfermenting 2 family, androgen receptor-interacting protein 4, is essential for mouse embryonic development and cell proliferation. Mol Endocrinol (2007) 0.78
[Glucocorticoids and aetiopathogenesis of depression]. Duodecim (2012) 0.77
Reduced circulating androgen bioactivity in patients with prostate cancer. Prostate (2003) 0.77
SUMO wrestling in cell movement. Cell Res (2010) 0.77
Small nuclear RING finger protein expression during gonad development: regulation by gonadotropins and estrogen in the postnatal ovary. Endocrinology (2004) 0.77
Identification of a short PIASx gene promoter that directs male germ cell-specific transcription in vivo. Biochem Biophys Res Commun (2003) 0.77
Overexpression of SUMO perturbs the growth and development of Caenorhabditis elegans. Cell Mol Life Sci (2011) 0.76
GC-rich elements flanking the transcription start site govern strong activation on the SNURF gene. Biochem Biophys Res Commun (2002) 0.75
Androgen receptor: acting in the three-dimensional chromatin landscape of prostate cancer cells. Horm Mol Biol Clin Investig (2011) 0.75
Firefly luciferase inhibitor-conjugated peptide quenches bioluminescence: a versatile tool for real time monitoring cellular uptake of biomolecules. Bioconjug Chem (2013) 0.75
Discovery of 5-benzyl-3-phenyl-4,5-dihydroisoxazoles and 5-benzyl-3-phenyl-1,4,2-dioxazoles as potent firefly luciferase inhibitors. J Med Chem (2013) 0.75
Synthesis and biological evaluation of second-generation tropanol-based androgen receptor modulators. J Med Chem (2015) 0.75
Design, synthesis, and biological evaluation of nonsteroidal cycloalkane[d]isoxazole-containing androgen receptor modulators. J Med Chem (2012) 0.75